Articles Tagged With:
-
HPV Vaccination Disparities Among Adult Women in the United States
A longitudinal, cross-sectional cohort study of 113,344 participants demonstrated that lack of health insurance, lack of stable employment, and lower income were significantly associated with decreased human papillomavirus vaccination uptake in women aged 18-47 years residing in the United States.
-
Doxy-PEP Could Be Prevention Strategy for Some Patients
Post-exposure prophylaxis (PEP) of doxycycline is recommended by the Centers for Disease Control and Prevention (CDC) for prevention of chlamydia, syphilis, and gonorrhea infections for men who have sex with men (MSM) and transgender women who have had a bacterial sexually transmitted infection (STI) within the past year, according to a new paper on doxycycline-PEP. But it also is a strategy that may work well for cisgender women who have a similar risk profile.
-
Routine, Opt-Out Screening for Syphilis in Emergency Departments Succeeds
The current healthcare crisis of increases in cases of congenital syphilis suggest reproductive health providers and the public health community need better strategies for identifying people with syphilis infection and getting them into treatment.
-
Study Suggests Some EC Clients Interested in Implants When They Have Access
Family planning clinics often have patients who ask for EC, and this is a prime opportunity to talk with them about their ongoing contraceptive needs.
-
Care of Cancer Patients and People with Chronic Illnesses in Jeopardy Since Dobbs
The U.S. Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization to allow states to ban abortion care has a broader impact than many physicians initially assumed. It can create barriers to women receiving many different types of medical care, including treatment for cancer.
-
State Shield Law Led to More People Accessing Medication Abortion
State Shield Laws, which protect providers and patients from criminal and civil investigations initiated in abortion-ban states, are successfully improving access to medication abortion, new research shows.
-
How the Dobbs Decision Has Changed Abortion Access and Care in the United States
This article reviews some of the chief reproductive healthcare challenges that have occurred since the U.S. Supreme Court’s decision to overturn Roe v. Wade with the June 2022 decision in Dobbs v. Jackson Women’s Health Organization.
-
Abortion Access and Pregnancy Dangers Continue
This issue will look at some of the repercussions of the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization and hear from providers and researchers on what can be done to mitigate the damage to their patients’ health and lives.
-
Lebrikizumab-lbkz Injection (Ebglyss)
The U.S. Food and Drug Administration has approved a humanized monoclonal antibody that targets interleukin-13 for the treatment of moderate-to-severe atopic dermatitis.
-
Metformin Reduces SARS-CoV-2 Viral Load in Outpatients with COVID-19
A randomized, placebo-controlled clinical trial of outpatients with COVID-19 found that metformin reduced SARS-CoV-2 viral load 3.6-fold compared to placebo, while ivermectin and fluvoxamine showed no benefit.